Bausch + Lomb is assessing interest from potential buyers as a way around the roadblock, the FT wrote. The company had a ...

Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...

Bausch + Lomb Corp. shares rose the most ever following a report that the eye-care company is considering selling itself to ...

In its latest warning letter, FDA raised concern that the company was still producing eye drops with amniotic fluid, even ...

Eye drops can help soothe dry eyes by giving them much-needed ... Buy now £8.99, Holland & Barrett Ocuvite Complete, Eye Supplement Capsules, by Bausch + Lomb From one of the world's leading eye ...

Laughter therapy for dry eye disease worked in reducing discomfort. It improved tear stability, gland function, and mental ...

The global ophthalmic eye drop market is poised for steady growth over the next decade. The market, which was valued at USD ...

A study reveals laughter exercise is as effective as artificial tears for dry eye disease, improving symptoms and tear film ...

People with dry eye syndrome use self-care to relieve severe and chronic symptoms. Learn what to do daily to control ongoing ...

Press Release Nicox and Glaukos Sign Exclusive NCX 1728 Research and Global Licensing Option AgreementOption entitles Glaukos to exclusive global ...

Bausch Health Cos. is working with Jefferies Financial Group to explore refinancing some of its debt to aid a long-planned ...

Investors are pouring money into corporate bonds, risk premiums are grinding tighter, and the Federal Reserve’s interest rate ...